Zasocitinib Landmark Ph3 Plaque Psoriasis Data Show Promise To Deliver Clear Skin
18/12/2025 08:01
Takeda Pharmaceutical Co Ltd 4502.T: TAKEDA PHARMACEUTICAL CO LTD - ZASOCITINIB LANDMARK PH3 PLAQUE PSORIASIS DATA SHOW PROMISE TO DELIVER CLEAR SKIN Source text: ID:nTSxr7f810 Further company coverage: 4502.T
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)